Filter
198
Text search:
ICAP
Featured
23
56
Language
Document type
146
21
11
8
7
3
1
Countries / Regions
15
13
9
9
8
5
5
4
4
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
86
56
9
5
4
1
Toolboxes
55
6
4
2
2
2
1
1
1
1
1
In 2014, GHS/NACP, with support from UNICEF and other partners, conducted a situation analysis on paediatric HIV care and treatment in Ghana. The purpose of this analysis was to identify the gaps within the current delivery of paediatric HIV care and support system and develop a road map for effecti
...
En la presente publicación se formulan orientaciones sobre la respuesta de salud pública a la farmacorresistencia del VIH (FRVIH) a inhibidores no nucleosídicos de la retrotranscriptasa (INNRT), previa al tratamiento, en personas con exposición previa a los fármacos antirretrovirales (ARV) o si
...
This implementation tool describes the recommended approaches for routine monitoring of toxicity integrated with the national monitoring and evaluation system and targeted approaches to monitoring toxicity to enable enhanced monitoring and reporting of treatment-limiting toxicity to support country
...
L'outil de l'OMS (2017) pour la surveillance de la toxicité des nouveaux ARV/antiviraux (VIH/hépatite) aide à implémenter une surveillance active dans les programmes de santé. Il cible la détection des effets indésirables (EI) via des méthodes standardisées, notamment des études de cohorte
...
Interim practical manual supporting implementation of the WHO guidelines on core components of infection prevention and control programmes
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w
...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w
...
